Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk

Summary

This large-scale genomic study, conducted across multiple international cohorts, identified hundreds of genetic variants influencing the timing of menarche and explored their association with cancer risk. The findings suggest that genetic factors regulating puberty timing may play a role in cancer aetiology, as suggested by the authors' analysis of linked health outcomes. The work contributes to understanding the biological mechanisms linking developmental timing to chronic disease susceptibility.

UK applicability

The findings are applicable to UK populations given the inclusion of UK-based cohorts in this international collaboration and the relevance of cancer risk stratification to UK public health surveillance and clinical genetics services. Genetic discoveries of this scale may inform risk profiling and preventive strategies in UK healthcare settings.

Key measures

Genetic variants (single nucleotide polymorphisms) associated with age at menarche; cancer incidence and risk stratification by puberty timing

Outcomes reported

The study identified hundreds of genetic variants associated with age at menarche through genome-wide association analysis across multiple cohorts. The research examined the relationship between puberty timing and subsequent cancer risk.

Topic tags